Melanoma cases were almost 10 times higher in high Human Development Index countries than in low.
2023
Dr McKean on the Rationale For Evaluating LAG-3 Inhibitors in Advanced Melanoma
Meredith McKean, MD, MPH, discusses the rationale for investigating the LAG-3 inhibitor fianlimab in combination with cemiplimab-rwlc in patients with advanced melanoma, highlighting the combination’s efficacy in both PD-1 inhibitor-exposed and –naïve populations, as well as the combinations its potential clinical significance within the advanced melanoma space.
Cancer diagnoses fell early in COVID pandemic, but many types eventually climbed again
A pair of new studies documents initial drops—and, in some cases, rebounds—in cancer diagnoses in Canada and the United States in the first year of the COVID-19 pandemic.
Hope for new therapy to stop advanced skin cancer
Researchers at St George’s, University of London have discovered a technique that can kill skin cancer cells while minimizing damage to healthy cells. The findings are published in the journal Biology Open.